Kazia Therapeutics
KZIA
5 hedge funds and large institutions have $491K invested in Kazia Therapeutics in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
15% less capital invested
Capital invested by funds: $580K → $491K (-$89K)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$47.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$430 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $257K | – | – | – |
|
|
2
Bank of America
Charlotte,
North Carolina
| $166K | -$430 | -1 | -0.2% |
|
|
3
Morgan Stanley
New York
| $54K | +$47.7K | +111 | +336% |
|
|
4
UBS Group
Zurich,
Switzerland
| $13K | +$10.3K | +24 | +240% |
|
5
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
KZIA Hedge Fund Activity: Q2 2016 in Review
5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2016, worth a combined $491K — down 15% from $580K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KZIA and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $47.7K. The largest seller was Bank of America, cutting an estimated $430.
- 5 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2016, down from 6 in Q1 2016.
- Funds reported $491K of Kazia Therapeutics stock for Q2 2016, down 15% quarter-over-quarter.
- 0 funds opened new Kazia Therapeutics positions in Q2 2016 and 1 closed out, a net change of -1 holder.
- The largest Kazia Therapeutics buyer in Q2 2016 was Morgan Stanley, an estimated $47.7K added.
- The largest Kazia Therapeutics seller in Q2 2016 was Bank of America, an estimated $430 sold.
Based on aggregated 13F filings for Q2 2016.